South Carolina Retina Institute (SCRI) can offer patients the latest advancement in the treatment of retinal vein occlusion (RVO) – the FDA-approved Genentech’s VABYSMO® (faricimab-svoa).
Advanced Care and Treatment for Macular Edema Associated with Uveitis
South Carolina Retina Institute (SCRI) may, for certain patient eye conditions, administer XIPERE® – a revolutionary therapeutic eye treatment that received FDA approval in October 2021.
Breakthrough Therapies for Geographic Atrophy Offer Patients Hope at SCRI
In the pursuit of providing state-of-the-art care for patients dealing with age-related macular degeneration (AMD) and geographic atrophy (GA), South Carolina Retina Institute (SCRI) is pleased to introduce